Starting April 1, investors will be able to store their demat account holding statements and consolidated account statements ...
Subject: Extension towards Adoption and Implementation of Cybersecurity and Cyber Resilience Framework (CSCRF) for SEBI Regulated Entities (REs) 2. SEBI had received multiple requests for CSCRF ...
The firm said its next-generation siRNA candidate showed in preclinical studies that it could reduce tumor growth and metastatic spread.
SEBI extends compliance deadline for Cybersecurity and Cyber Resilience Framework until June 30, 2025, except for certain entities.
The market regulator has once again extended the deadline for registered entities (REs) to adopt Cybersecurity and Cyber ...
BMS is already testing the combo against just Keytruda as a first-line treatment in a Phase III trial in KRAS G12C-mutant and ...
These days, along with the relief of having a stable job, comes a load of added stress- with work pressure mounting up day on ...
The capital markets regulator has extended the deadline for regulated entities to implement the Cybersecurity and Cyber Resilience Framework (CSCRF) by three months to June 30. This decision follows ...
The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...
Sebi has extended the deadline for regulated entities to adopt a cybersecurity framework to June 2025, citing requests for ...
Sebi has extended the deadline by three months for regulated entities to implement a cybersecurity and cyber resilience ...
Suzhou Zion Pharma Technology Co. Ltd. has identified GTPase KRAS G12D or G13D mutant and/or KRAS inhibitors reported to be useful for the treatment of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results